University of Illinois

AI tools have impressive potential in personalizing treatments, but doctors are concerned about bias, generalizability, and the lack of prospective validation.

The platform, from a University of Illinois at Chicago-led team, separates circulating tumor cells from other cell types using size-dependent inertial migration.